Alessia Savoldi

8.5k total citations · 1 hit paper
36 papers, 1.4k citations indexed

About

Alessia Savoldi is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Molecular Medicine. According to data from OpenAlex, Alessia Savoldi has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Applied Microbiology and Biotechnology and 7 papers in Molecular Medicine. Recurrent topics in Alessia Savoldi's work include Antibiotic Use and Resistance (11 papers), COVID-19 Clinical Research Studies (7 papers) and Antibiotic Resistance in Bacteria (7 papers). Alessia Savoldi is often cited by papers focused on Antibiotic Use and Resistance (11 papers), COVID-19 Clinical Research Studies (7 papers) and Antibiotic Resistance in Bacteria (7 papers). Alessia Savoldi collaborates with scholars based in Italy, Germany and United Kingdom. Alessia Savoldi's co-authors include Evelina Tacconelli, Elena Carrara, David Y. Graham, Michela Conti, Antonella d’Arminio Monforte, Elda Righi, Ottavia Viganò, Mattia Trunfio, Giulia Marchetti and Anna Maria Azzini and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Alessia Savoldi

31 papers receiving 1.4k citations

Hit Papers

Prevalence of Antibiotic ... 2018 2026 2020 2023 2018 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessia Savoldi Italy 15 836 345 258 252 228 36 1.4k
Peter J. Jenks United Kingdom 20 885 1.1× 214 0.6× 424 1.6× 90 0.4× 61 0.3× 48 1.6k
I Mura Italy 20 269 0.3× 106 0.3× 271 1.1× 183 0.7× 56 0.2× 60 1.1k
Jill Beyer United States 31 807 1.0× 533 1.5× 938 3.6× 325 1.3× 149 0.7× 62 2.8k
K. J. Christiansen Australia 15 231 0.3× 61 0.2× 491 1.9× 99 0.4× 64 0.3× 23 904
Kiran Chawla India 18 278 0.3× 68 0.2× 333 1.3× 162 0.6× 24 0.1× 123 1.1k
Mark LaRocco United States 23 281 0.3× 48 0.1× 606 2.3× 180 0.7× 48 0.2× 61 1.9k
T. Justesen Denmark 23 605 0.7× 98 0.3× 177 0.7× 211 0.8× 189 0.8× 69 1.2k
J.P. Thys Belgium 22 295 0.4× 69 0.2× 307 1.2× 295 1.2× 13 0.1× 62 1.3k
Pankaj Singh India 18 205 0.2× 33 0.1× 647 2.5× 135 0.5× 33 0.1× 64 1.4k
A. Colville United Kingdom 11 129 0.2× 69 0.2× 436 1.7× 176 0.7× 52 0.2× 13 1.1k

Countries citing papers authored by Alessia Savoldi

Since Specialization
Citations

This map shows the geographic impact of Alessia Savoldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia Savoldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia Savoldi more than expected).

Fields of papers citing papers by Alessia Savoldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia Savoldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia Savoldi. The network helps show where Alessia Savoldi may publish in the future.

Co-authorship network of co-authors of Alessia Savoldi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessia Savoldi. A scholar is included among the top collaborators of Alessia Savoldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessia Savoldi. Alessia Savoldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gentilotti, Elisa, Lorenzo Maria Canziani, Anna Maria Azzini, et al.. (2025). ORCHESTRA Delphi consensus: diagnostic and therapeutic management of post-COVID-19 condition in vulnerable populations. Clinical Microbiology and Infection. 31(8). S44–S54.
2.
Garlasco, Jacopo, Diletta Pezzani, Alessandro Cassini, et al.. (2025). The Emerging Resistance Index: tracking early resistance to new antibiotics. The Lancet Infectious Diseases. 1 indexed citations
3.
Gupta, Akshita, Matilda Berkell, Alessia Savoldi, et al.. (2023). Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments. Journal of Clinical Investigation. 133(6). 24 indexed citations
4.
Luxi, Nicoletta, Pasquale De Nardo, Alessia Savoldi, et al.. (2023). Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy. BioDrugs. 37(5). 675–684. 2 indexed citations
5.
Nardo, Pasquale De, Alessia Savoldi, Elisa Danese, et al.. (2023). Diagnostic Accuracy of a Rapid SARS-CoV-2 Antigen Test Among People Experiencing Homelessness: A Prospective Cohort and Implementation Study. Infectious Diseases and Therapy. 12(4). 1073–1082. 3 indexed citations
6.
Mazzaferri, Fulvia, Massimo Mirandola, Alessia Savoldi, et al.. (2022). Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern. eLife. 11. 14 indexed citations
7.
Savoldi, Alessia, Massimo Mirandola, Matilda Berkell, et al.. (2022). Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study. Biomedicines. 10(9). 2063–2063. 3 indexed citations
8.
Scudeller, Luigia, Elda Righi, Damiano Bragantini, et al.. (2021). Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli. International Journal of Antimicrobial Agents. 57(5). 106344–106344. 74 indexed citations
9.
Savoldi, Alessia, Elena Carrara, Laura J. V. Piddock, et al.. (2021). The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies. BMC Infectious Diseases. 21(1). 545–545. 26 indexed citations
10.
Carrara, Elena, Alessia Savoldi, Laura J. V. Piddock, et al.. (2021). Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations. Clinical Microbiology and Infection. 28(1). 66–72. 15 indexed citations
11.
Savoldi, Alessia, Elena Carrara, & Evelina Tacconelli. (2020). Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list—authors’ response. Journal of Antimicrobial Chemotherapy. 75(7). 2018–2018. 6 indexed citations
12.
Savoldi, Alessia, Federico Foschi, Beryl Primrose Gladstone, et al.. (2020). Impact of implementing a non-restrictive antibiotic stewardship program in an emergency department: a four-year quasi-experimental prospective study. Scientific Reports. 10(1). 8194–8194. 11 indexed citations
13.
Savoldi, Alessia, Giuseppe Granata, Gianluigi Arrigoni, et al.. (2020). An unusual case of melanoma metastasis in the buccal space: learning by mistakes to distinguish it from salivary neoplasms. Oral Radiology. 37(1). 146–152. 1 indexed citations
14.
Schweitzer, Valentijn A., Cornelis H. van Werkhoven, Jesús Rodríguez‐Baño, et al.. (2019). Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group. Clinical Microbiology and Infection. 26(1). 41–50. 53 indexed citations
15.
Savoldi, Alessia, Elena Carrara, Beryl Primrose Gladstone, et al.. (2019). Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list. Journal of Antimicrobial Chemotherapy. 74(12). 3619–3625. 32 indexed citations
16.
Savoldi, Alessia, Elena Carrara, David Y. Graham, Michela Conti, & Evelina Tacconelli. (2018). Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology. 155(5). 1372–1382.e17. 861 indexed citations breakdown →
17.
Trunfio, Mattia, Alessia Savoldi, Ottavia Viganò, & Antonella d’Arminio Monforte. (2016). Bacterial coinfections in dengue virus disease: what we know and what is still obscure about an emerging concern. Infection. 45(1). 1–10. 39 indexed citations
18.
Nardo, Pasquale De, Elisa Gentilotti, Boniface Nguhuni, et al.. (2016). Post-caesarean section surgical site infections at a Tanzanian tertiary hospital: a prospective observational study. Journal of Hospital Infection. 93(4). 355–359. 49 indexed citations
19.
Gazzola, Lidia, Alessia Savoldi, Elisa Suardi, et al.. (2014). Association between abdominal aortic calcifications, bone mineral density and vertebral fractures in a cohort of HIV‐positive patients. Journal of the International AIDS Society. 17(4S3). 19715–19715. 2 indexed citations
20.
Marchetti, Giulia, Esther Merlini, Elisabetta Sinigaglia, et al.. (2012). Immune Reconstitution in HIV+ Subjects on Lopinavir/Ritonavir-Based HAART According to the Severity of Pre-Therapy CD4+. Current HIV Research. 10(7). 597–605. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026